These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38727812)

  • 1. Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score.
    Zhang C; Li S; Shen L; Teng X; Xiao Y; Yang W; Lu Z
    Cancer Immunol Immunother; 2024 May; 73(7):123. PubMed ID: 38727812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
    Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
    J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.
    Shitaoka K; Hamana H; Kishi H; Hayakawa Y; Kobayashi E; Sukegawa K; Piao X; Lyu F; Nagata T; Sugiyama D; Nishikawa H; Tanemura A; Katayama I; Murahashi M; Takamatsu Y; Tani K; Ozawa T; Muraguchi A
    Cancer Immunol Res; 2018 Apr; 6(4):378-388. PubMed ID: 29475880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures.
    Li Z; Ma L; Gao Z; Wang X; Che X; Zhang P; Li Y; Zhang Q; Liu T; Sun Y; Bai Y; Deng H
    Cancer Immunol Immunother; 2024 Jul; 73(9):164. PubMed ID: 38954022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 6. An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.
    Lu YC; Zheng Z; Robbins PF; Tran E; Prickett TD; Gartner JJ; Li YF; Ray S; Franco Z; Bliskovsky V; Fitzgerald PC; Rosenberg SA
    Mol Ther; 2018 Feb; 26(2):379-389. PubMed ID: 29174843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application.
    Wang X; Dai Z; Lin X; Zou X; Wang R; Tasiheng Y; Yan Y; Ma M; Chen Y; Cheng H; Liu C; Yu X
    Cancer Lett; 2024 Apr; 588():216741. PubMed ID: 38395378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes.
    Levin N; Kim SP; Marquardt CA; Vale NR; Yu Z; Sindiri S; Gartner JJ; Parkhurst M; Krishna S; Lowery FJ; Zacharakis N; Levy L; Prickett TD; Benzine T; Ray S; Masi RV; Gasmi B; Li Y; Islam R; Bera A; Goff SL; Robbins PF; Rosenberg SA
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
    Guo X; Zhang Y; Zheng L; Zheng C; Song J; Zhang Q; Kang B; Liu Z; Jin L; Xing R; Gao R; Zhang L; Dong M; Hu X; Ren X; Kirchhoff D; Roider HG; Yan T; Zhang Z
    Nat Med; 2018 Jul; 24(7):978-985. PubMed ID: 29942094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    He D; Wang D; Lu P; Yang N; Xue Z; Zhu X; Zhang P; Fan G
    Oncogene; 2021 Jan; 40(2):355-368. PubMed ID: 33144684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning for the identification of neoantigen-reactive CD8 + T cells in gastrointestinal cancer using single-cell sequencing.
    Sun H; Han X; Du Z; Chen G; Guo T; Xie F; Gu W; Shi Z
    Br J Cancer; 2024 Jul; 131(2):387-402. PubMed ID: 38849478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR function analysis using a novel system reveals the multiple unconventional tumor-reactive T cells in human breast cancer-infiltrating lymphocytes.
    Yamaguchi S; Hamana H; Shitaoka K; Sukegawa K; Nagata T; Hayee A; Kobayashi E; Ozawa T; Fujii T; Muraguchi A; Tobe K; Kishi H
    Eur J Immunol; 2021 Sep; 51(9):2306-2316. PubMed ID: 34171120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid identification of tumor-reactive T-cell receptors by RNA preamplification-based single-cell sequencing.
    Ma Y; Liu F; Li B; Zhou H; Qiao D; Deng L; Wu H; Fang F; Wang Y; Yao D; Hu G; Qian Y; Wang M
    J Immunol Methods; 2022 May; 504():113260. PubMed ID: 35331733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.
    Hanada KI; Zhao C; Gil-Hoyos R; Gartner JJ; Chow-Parmer C; Lowery FJ; Krishna S; Prickett TD; Kivitz S; Parkhurst MR; Wong N; Rae Z; Kelly MC; Goff SL; Robbins PF; Rosenberg SA; Yang JC
    Cancer Cell; 2022 May; 40(5):479-493.e6. PubMed ID: 35452604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
    Liu J; Yang X; Lu X; Zhang L; Luo W; Cheng Y; Zhang L; Yang Y; Dai N; Xu Y; Guan Y; Xiao H; Li M; Wang D
    Exp Cell Res; 2020 Sep; 394(2):112134. PubMed ID: 32540399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
    Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface marker-based capture of neoantigen-reactive CD8
    Chatani PD; Lowery FJ; Parikh NB; Hitscherich KJ; Yossef R; Hill V; Gartner JJ; Paria B; Florentin M; Ray S; Bera A; Parkhust M; Robbins P; Krishna S; Rosenberg SA
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
    Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.